–News Direct– By John Biggs In the wake of a significant reduction in U.S. venture capital (VC) funding, which dropped from $345 billion in 2021 to $238 billion in 2022, there has been a marked shift towards non-dilutive funding among…

–News Direct– By Faith Ashmore, Benzinga Oncotelic Therapeutics (OTCQB: OTLC) is a clinical-stage biopharmaceutical company. Its primary focus is on developing innovative drugs for oncology and infectious disease and aging. OT-101 is the companys lead immuno-oncology drug candidate, showing promise…

–News Direct– The world has collectively turned its attention towards nuclear energy as a saving grace for clean energy solutions, investments are continuing to pour into the space. The latest capital to hit the uranium sector was a $11 million…